-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Stride, Lowers Price Target to $125

Benzinga·10/29/2025 20:45:47
Listen to the news
Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and lowers the price target from $175 to $125.